ITRM20010136A0 - Composti utili per il trattamento di patologie che rispondono all'attivazione del recettore ppar-gamma. - Google Patents
Composti utili per il trattamento di patologie che rispondono all'attivazione del recettore ppar-gamma.Info
- Publication number
- ITRM20010136A0 ITRM20010136A0 IT2001RM000136A ITRM20010136A ITRM20010136A0 IT RM20010136 A0 ITRM20010136 A0 IT RM20010136A0 IT 2001RM000136 A IT2001RM000136 A IT 2001RM000136A IT RM20010136 A ITRM20010136 A IT RM20010136A IT RM20010136 A0 ITRM20010136 A0 IT RM20010136A0
- Authority
- IT
- Italy
- Prior art keywords
- ppar
- respond
- diseases
- activation
- treatment
- Prior art date
Links
- 230000004913 activation Effects 0.000 title 1
- 150000001875 compounds Chemical class 0.000 title 1
- 201000010099 disease Diseases 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Diabetes (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Oncology (AREA)
- Emergency Medicine (AREA)
- Obesity (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Peptides Or Proteins (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Priority Applications (26)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT2001RM000136A ITRM20010136A1 (it) | 2001-03-16 | 2001-03-16 | Composti utili per il trattamento di patologie che rispondono all'attivazione del recettore ppar-gamma. |
PL02369295A PL369295A1 (en) | 2001-03-16 | 2002-03-01 | Compositions useful for the treatment of pathologies responding to the activation of ppar-gamma receptor |
JP2002572999A JP4276842B2 (ja) | 2001-03-16 | 2002-03-01 | Ppar−ガンマ受容体の活性化に応答する症状の治療に有用な組成物 |
DE60207215T DE60207215T2 (de) | 2001-03-16 | 2002-03-01 | Arzneiformen zur behandlung von krankheiten, die auf aktivierung des ppar-gamma-rezeptors ansprechen |
CZ20032523A CZ20032523A3 (cs) | 2001-03-16 | 2002-03-01 | Přípravek vhodný k léčbě patologické reakce na aktivaci PPAR gamma receptoru |
EP02717031A EP1368025B1 (en) | 2001-03-16 | 2002-03-01 | Compositions useful for the treatment of pathologies responding to the activation of ppar-gamma receptor |
ES02717031T ES2249568T3 (es) | 2001-03-16 | 2002-03-01 | Composiciones utiles para el tratamiento de patologias que responden a la activacion del receptor ppar-gamma. |
MXPA03008317A MXPA03008317A (es) | 2001-03-16 | 2002-03-01 | Composiciones utiles para el tratamiento de patologias que responden a la activavion del receptor ppar-gama. |
AT02717031T ATE308984T1 (de) | 2001-03-16 | 2002-03-01 | Arzneiformen zur behandlung von krankheiten, die auf aktivierung des ppar-gamma-rezeptors ansprechen |
CA2440979A CA2440979C (en) | 2001-03-16 | 2002-03-01 | Spirolaximes for use in the treatment of pathologies that respond to ppar-.gamma. receptor activation |
DK02717031T DK1368025T3 (da) | 2001-03-16 | 2002-03-01 | Præparater, der er nyttige til behandling af patologier, som udviser respons på aktiveringen af PPAR-gammareceptor |
SI200230214T SI1368025T1 (sl) | 2001-03-16 | 2002-03-01 | Zmesi, ki so uporabne za zdravljenje patologij odzivanja na aktiviranje PPAR-gama receptorja |
CNB2006100057819A CN100462073C (zh) | 2001-03-16 | 2002-03-01 | 用于治疗对PPAR-γ受体的活化有响应的病变的组合物 |
AU2002247951A AU2002247951B2 (en) | 2001-03-16 | 2002-03-01 | Compositions useful for the treatment of pathologies responding to the activation of ppar-gamma receptor |
US10/471,786 US6897235B2 (en) | 2001-03-16 | 2002-03-01 | Compositions useful for the treatment of pathologies responding to the activation of PPAR-γ receptor |
PCT/IT2002/000127 WO2002074291A2 (en) | 2001-03-16 | 2002-03-01 | Compositions useful for the treatment of pathologies responding to the activation of ppar-gamma receptor |
SK1275-2003A SK12752003A3 (sk) | 2001-03-16 | 2002-03-01 | Prípravky užitočné na liečbu patológií odpovedajúce na aktiváciu PPAR-gamma receptora |
BR0208157-1A BR0208157A (pt) | 2001-03-16 | 2002-03-01 | Composições úteis para o tratamento de patologias respondendo à ativação de receptor ppar-gama |
HU0303518A HUP0303518A3 (en) | 2001-03-16 | 2002-03-01 | Compositions useful for the treatment of pathologies responding to the activation of ppar-gamma receptor |
KR1020037012030A KR100851678B1 (ko) | 2001-03-16 | 2002-03-01 | Ppar-감마 수용체의 활성화에 반응하는 질병의 치료에유용한 조성물 |
CNB028081382A CN1286456C (zh) | 2001-03-16 | 2002-03-01 | 螺莱素用于制备治疗2型抗胰岛素性糖尿病的药物的应用 |
US10/889,030 US20040242675A1 (en) | 2001-03-15 | 2004-07-13 | Compositions useful for the treatment of pathologies responding to the activation of PPAR-gamma receptor |
US10/889,029 US7276533B2 (en) | 2001-03-16 | 2004-07-13 | Compositions useful for the treatment of pathologies responding to the activation of PPAR-gamma receptor |
US10/965,740 US20050131060A1 (en) | 2001-03-16 | 2004-10-18 | Compositions useful for the treatment of pathologies responding to the activation of PPAR-gamma receptor |
HK05107335A HK1075006A1 (en) | 2001-03-16 | 2005-08-22 | Use of spirolaxine for the preparation of a medicament treating type 2 insulin-resistant diabetes mellitus |
HK07101784.1A HK1096850A1 (en) | 2001-03-16 | 2007-02-15 | Compositions useful for the treatment of pathologies responding to the activation of ppar-gamma receptor |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT2001RM000136A ITRM20010136A1 (it) | 2001-03-16 | 2001-03-16 | Composti utili per il trattamento di patologie che rispondono all'attivazione del recettore ppar-gamma. |
Publications (2)
Publication Number | Publication Date |
---|---|
ITRM20010136A0 true ITRM20010136A0 (it) | 2001-03-16 |
ITRM20010136A1 ITRM20010136A1 (it) | 2002-09-16 |
Family
ID=11455333
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IT2001RM000136A ITRM20010136A1 (it) | 2001-03-15 | 2001-03-16 | Composti utili per il trattamento di patologie che rispondono all'attivazione del recettore ppar-gamma. |
Country Status (20)
Country | Link |
---|---|
US (4) | US6897235B2 (it) |
EP (1) | EP1368025B1 (it) |
JP (1) | JP4276842B2 (it) |
KR (1) | KR100851678B1 (it) |
CN (2) | CN1286456C (it) |
AT (1) | ATE308984T1 (it) |
AU (1) | AU2002247951B2 (it) |
BR (1) | BR0208157A (it) |
CA (1) | CA2440979C (it) |
CZ (1) | CZ20032523A3 (it) |
DE (1) | DE60207215T2 (it) |
DK (1) | DK1368025T3 (it) |
ES (1) | ES2249568T3 (it) |
HK (2) | HK1075006A1 (it) |
HU (1) | HUP0303518A3 (it) |
IT (1) | ITRM20010136A1 (it) |
MX (1) | MXPA03008317A (it) |
PL (1) | PL369295A1 (it) |
SK (1) | SK12752003A3 (it) |
WO (1) | WO2002074291A2 (it) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20070082947A1 (en) * | 2003-05-14 | 2007-04-12 | D Orazio Daniel | Use of phthalide derivatives for the treatment and prevention of diabetes mellitus |
JP2010502719A (ja) | 2006-09-08 | 2010-01-28 | ロード アイランド ホスピタル | アルコール誘発性脳疾患の治療、予防および回復 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH07285862A (ja) | 1994-04-21 | 1995-10-31 | Kokka Iyaku Kanrikyoku Shisen Kokinso Kogyo Kenkyusho | 脂質低下剤 |
JPH107557A (ja) | 1996-06-17 | 1998-01-13 | Banyu Pharmaceut Co Ltd | 抗腫瘍性物質スピロラキシン |
US6440961B1 (en) * | 1997-10-27 | 2002-08-27 | Dr. Reddy's Research Foundation | Tricyclic compounds and their use in medicine: process for their preparation and pharmaceutical compositions containing them |
IT1317001B1 (it) * | 2000-03-13 | 2003-05-26 | Sigma Tau Ind Farmaceuti | Uso della spirolaxina per il trattamento di patologie associate ad unaalterata angiogenesi. |
-
2001
- 2001-03-16 IT IT2001RM000136A patent/ITRM20010136A1/it unknown
-
2002
- 2002-03-01 SK SK1275-2003A patent/SK12752003A3/sk unknown
- 2002-03-01 KR KR1020037012030A patent/KR100851678B1/ko not_active IP Right Cessation
- 2002-03-01 AT AT02717031T patent/ATE308984T1/de not_active IP Right Cessation
- 2002-03-01 EP EP02717031A patent/EP1368025B1/en not_active Expired - Lifetime
- 2002-03-01 JP JP2002572999A patent/JP4276842B2/ja not_active Expired - Fee Related
- 2002-03-01 BR BR0208157-1A patent/BR0208157A/pt not_active IP Right Cessation
- 2002-03-01 CN CNB028081382A patent/CN1286456C/zh not_active Expired - Fee Related
- 2002-03-01 CN CNB2006100057819A patent/CN100462073C/zh not_active Expired - Fee Related
- 2002-03-01 MX MXPA03008317A patent/MXPA03008317A/es active IP Right Grant
- 2002-03-01 DK DK02717031T patent/DK1368025T3/da active
- 2002-03-01 CA CA2440979A patent/CA2440979C/en not_active Expired - Fee Related
- 2002-03-01 DE DE60207215T patent/DE60207215T2/de not_active Expired - Lifetime
- 2002-03-01 AU AU2002247951A patent/AU2002247951B2/en not_active Ceased
- 2002-03-01 US US10/471,786 patent/US6897235B2/en not_active Expired - Fee Related
- 2002-03-01 ES ES02717031T patent/ES2249568T3/es not_active Expired - Lifetime
- 2002-03-01 HU HU0303518A patent/HUP0303518A3/hu unknown
- 2002-03-01 PL PL02369295A patent/PL369295A1/xx not_active Application Discontinuation
- 2002-03-01 WO PCT/IT2002/000127 patent/WO2002074291A2/en active IP Right Grant
- 2002-03-01 CZ CZ20032523A patent/CZ20032523A3/cs unknown
-
2004
- 2004-07-13 US US10/889,029 patent/US7276533B2/en not_active Expired - Fee Related
- 2004-07-13 US US10/889,030 patent/US20040242675A1/en not_active Abandoned
- 2004-10-18 US US10/965,740 patent/US20050131060A1/en not_active Abandoned
-
2005
- 2005-08-22 HK HK05107335A patent/HK1075006A1/xx not_active IP Right Cessation
-
2007
- 2007-02-15 HK HK07101784.1A patent/HK1096850A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60218493D1 (de) | Substituierte 7-aza-ä2.2.1übicycloheptane für die behandlung von krankheiten | |
AP2004002982A0 (en) | Urea-compounds active as vanilloid receptor antagonists for the treatment of pain. | |
ATE551340T1 (de) | Azabicyclisch- substituierte annelierte heteroaryl-verbinungen für die behandlung von krankheiten | |
IS7099A (is) | Efnasambönd til að meðhöndla bólgutruflanir | |
NO20053077D0 (no) | Terapeutiske formuleringer for behandling av beta-amyloid-relaterte sykdommer. | |
EA200300717A1 (ru) | Гетероциклилиндазольные и -азаиндазольные соединения в качестве 5-гидрокситриптамин-6-лигандов | |
BR0212250B1 (pt) | produto de cuidado pessoal. | |
ATE512594T1 (de) | Verbesserung des zustandes älterer haustiere | |
DK1562932T3 (da) | 4 tetrazolyl-4-phenylpiperidinderivater til behandling af smerter | |
ATE304530T1 (de) | Substituierte 1,5-dihydropyrrol-2-on-derivate wirksam als nmda-rezeptor-antagonisten für die behandlung von schmerzzuständen | |
ITMI20031311A0 (it) | Formulazioni per il trattamento di disturbi artrosici | |
NO20033803D0 (no) | Karbamat for behandling av bevegelseslidelser | |
ITMI20020773A1 (it) | Farmaci per il trattamento dell'artrite | |
NO20014241D0 (no) | C16-umettede FP-selektive prostaglandinanaloger | |
NO20033804D0 (no) | Karbamatforbindelser for behandling av smerte | |
ITGE20020050A0 (it) | Procedimento per il trattamento di filati mediante agugliatura. | |
ITRM20010136A0 (it) | Composti utili per il trattamento di patologie che rispondono all'attivazione del recettore ppar-gamma. | |
NO20053562L (no) | Nye aminobenzofenonforbindelser | |
IT1320192B1 (it) | Composizione terapeutica per la cura della psoriasi. | |
ATE277924T1 (de) | Aryl-8-azabicyclo(3.2.1)octanes für die behandlung von depression | |
DE60124791D1 (de) | S-Methyl-Dihydro-Ziprasidone zur Behandlung von psychiatrischen Störungen. | |
IS6020A (is) | S-nítrósóþíól til meðferðar við blóðrásartruflunum | |
ITMI20011284A0 (it) | Composizione farmaceutica per il trattamento dell'iperfosfatemia | |
EA200200750A1 (ru) | Новое терапевтическое применение еноксапарина | |
DE50310743D1 (de) | Wässrige formulierungen von (2-hydroxymethyl-indanyl-4-oxy)-phenyl-4,4,4- trifluorbutan-1-sulfonat |